Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,316 public trials 525 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors

NCT02644460

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +40 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta, Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Completed

A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL.

NCT02417285

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Local Institution - 105 Borddeaux Cedex, France
  • Local Institution - 102 Marseille, France
  • Local Institution - 103 Pierre-Bénite, France
  • Local Institution - 101 Villejuif, France
View Trial Details
Completed

A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

NCT04198415

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 239524 Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital /ID# 225300 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 240820 Nagoya, Aichi-ken, Japan
  • Toyohashi Municipal Hospital /ID# 227433 Toyohashi, Aichi-ken, Japan
View all 102 locations
View Trial Details
Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT05338892

Conditions
Chronic Disease, Diffuse Large B-cell Lymphoma, Disease Attributes, +20 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details
Completed

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

NCT04721002

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Tulane School of Medicine /ID# 223864 New Orleans, Louisiana, United States
  • University of Texas Southwestern Medical Center /ID# 223865 Dallas, Texas, United States
  • Hospital Italiano de Buenos Aires /ID# 224153 Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
  • Alfred Health /ID# 224386 Melbourne, Victoria, Australia
View all 40 locations
View Trial Details

Related conditions